Security, AI and enterprise software
CrowdStrike (CRWD) continues to expand ecosystem reach—bringing Falcon to Google Cloud, extending to Snowflake, and partnering with Cognizant—moves that aim to centralize AI‑era security telemetry and ease enterprise adoption. Today CrowdStrike also rolled out an AI Partner Specialization, formalizing an ecosystem play that helps channel partners certify AI‑centric services and could speed enterprise deployments.
SailPoint (SAIL) announced an integration with CrowdStrike Falcon Next‑Gen SIEM, which complements Falcon’s reach and could strengthen identity‑contextualized threat detection for joint customers.
Tenable (TENB) joined the White House‑led Project Watershed to boost cybersecurity for U.S. water systems. For investors, that widens Tenable’s government footprint and highlights cyber providers’ role in critical‑infrastructure resilience.
Biotech, approvals, clinical readouts and corporate R&D
Alvotech (ALVO) had its BLA for AVT80 accepted by the FDA, moving its Entyvio® biosimilar closer to commercialization.
PMV Pharmaceuticals (PMVP) shared updated interim PYNNACLE data for rezatapopt in ovarian cancer that the company calls promising, while also launching a proposed public offering. The twin updates combine scientific momentum with near‑term capital needs—watch dilution risk alongside binary clinical milestones.
Kazia Therapeutics (KZIA) closed an oversubscribed up-to-$120M public offering, a strong financing signal that gives more runway for clinical programs and reduces near‑term funding overhang.
NeuroSense (NRSN) unveiled an accelerated, capital‑efficient plan for PrimeC in ALS to trim cash burn and clarify milestones.
SciSparc (SPRC) said subsidiary NeuroThera Labs has achieved significant enrollment momentum in the SCI‑210 autism trial, a development that can materially shorten timelines for proof‑of‑concept updates.
AIM ImmunoTech (AIM) secured a broad U.S. patent for rintatolimod with pembrolizumab, extending IP protection through 2039 and preserving long‑term strategic optionality.
Daré Bioscience (DARE) secured about $908,000 in NIH funding to advance DARE‑PTB2, a modest non‑dilutive boost to its reproductive‑health program.
International expansion and consumer health moves
Hims & Hers (HIMS) entered Australia—its first Asia‑Pacific market—launching personalized men's care nationwide (announcement, local rollout). Geographic expansion can lift top‑line optionality but brings upfront marketing and regulatory costs to monitor.
AMC Entertainment (AMC) created “Leawood Films”, an in‑house distribution arm aimed at getting more titles onto the big screen. For media investors, that’s a vertical integration bet to boost theater content and potentially share in downstream film economics.
Sono Group N.V. (SEV) signed a letter of intent with Sports One to combine and expand into professional sports franchise ownership. The move diversifies Sono’s consumer‑mobility profile into entertainment assets—a strategic pivot worth watching for execution risk and capital needs.
Energy transition, batteries, project finance and M&A
NeoVolta (NEOV) announced a U.S. battery‑cell supply and BESS manufacturing collaboration with SK On, which may ease cell constraints and improve unit economics for storage deployments.
Smackover Lithium (SLI) signed a binding offtake with LG Energy Solution, de‑risking project financing and anchoring long‑term revenues.
ARRAY Technologies (ARRY) completed the acquisition of Affordable Wire Management, expanding its balance‑of‑system footprint and strengthening integration across solar project supply chains—moves that can protect margins as deployment scales (details).
Ameresco (AMRC) joined Neogenyx Fuels and Adams Land & Cattle to celebrate the groundbreaking of a renewable natural gas facility in Nebraska (announcement), a tangible example of project execution in low‑carbon fuel supply chains that can support long‑term contracted revenues.
Delek (DK) welcomed recent administration decisions on 2025 Small Refinery Exemptions (statement), a regulatory outcome that may ease compliance costs for refiners and affect regional fuel economics.
Semiconductors, quantum and advanced tech
Credo (CRDO) reported PCIe® progress and now joined the Open CPX MSA organization, signaling broader ecosystem support that can accelerate integration with hyperscale and OEM customers.
QTREX (QTEX) corrected prior disclosure while clarifying it has cryogenic interconnect capacity exceeding public benchmarks by more than fourfold—an important scalability data point for quantum hardware followers.
Planet (PL) shipped a Tanager‑2 and 18 SuperDove satellites to the launch site (logistics update), a cadence that maintains commercial revisit rates and sustains imagery revenue visibility.
Pasqal (PSQL) launched a strategic quantum research collaboration with KACST, reflecting continued international investment in quantum R&D and potential funding pathways.
Infrastructure, defense and industrial wins
Telos Corporation (TLS) picked up a $34.3 million task order for Air Force intelligence support, reinforcing stable defense services demand.
IperionX (IPX) secured a second U.S. Army task order to boost domestic titanium production—an example of onshoring translating into awarded work.
Deals, capital markets and corporate moves
Gilat (GILT) priced a $100 million convertible‑notes offering with a 60% conversion premium to shore liquidity while limiting short‑term dilution.
GDEV (GDEV) launched a self‑tender to repurchase up to $20.0 million of shares at $11.03, signaling management focus on capital allocation.
Wellchange Holdings (WCT) closed a $7.5 million public offering, a liquidity step that modestly expands working capital for growth initiatives.
BranchOut Food (BOF) exercised an over‑allotment option in its public offering, a sign of investor demand that slightly expands proceeds for growth initiatives (announcement).
Kyntra Bio (KYNB) reported a material reduction in royalty financing obligations, a balance‑sheet transformation that limits future cash‑flow pressure and reduces refinancing risk (details).
IHT (IHT) added $3 million in equity and cut debt as reverse merger talks continue, a short‑term liquidity move that preserves optionality for strategic transactions.
DeFi Development Corp. (DFDV) announced a proposed IPO of variable‑rate Series C perpetual preferred stock, an atypical capital‑raising structure that investors should parse for dilution and voting impacts.
Corporate events, investor days and conferences
- SolarEdge (SEDG) will webcast its 2026 Investor Day, which may offer updated market outlook and strategy signals for rooftop and commercial solar demand.
- GRAIL (GRAL) will present at Morgan Stanley’s healthcare conference, a stage often used to highlight near‑term clinical or commercial catalysts (details).
- AIB Data Centers (AIB) plans to attend three upcoming investor conferences in September 2026 (notice), a roadshow effort to broaden investor coverage.
- Karman Space & Defense (KRMN) will participate in upcoming investor conferences, a chance to expand institutional visibility ahead of program milestones.
Management, governance and operational updates
Charter (CHTR) announced a CFO transition, a high‑visibility leadership change that investors watch for guidance continuity and capital allocation priorities.
Kohl's (KSS) named Ryan M. Waymire as Chief Merchandising Officer, a hire that matters for merchandising strategy and gross‑margin trajectories as Kohl’s navigates retail headwinds.
Align Technology (ALGN) will add Quentin Blackford to its board, a governance move that can influence strategic oversight as Align navigates orthodontic device demand cycles.
Lifeward (LFWD) appointed Josh Hexter as interim CEO and Rami Aviram as CFO, signaling a near‑term leadership reset that investors will parse for strategic continuity.
Acrivon Therapeutics (ACRV) appointed Michaela Levin, Ph.D. as Chief Business Officer to accelerate business development and licensing efforts.
Definium Therapeutics (DFTX) announced new employee inducement grants, a routine retention step that matters most for small biotech teams with near‑term catalysts (release).
Selected strategic partnerships and customer wins
Cyabra (CYAB) disclosed a significant engagement with a Fortune Global 500 food and beverage leader, improving commercial referenceability for its brand‑safety tech.
Genasys (GNSS) teamed with PulsePoint to enhance situational awareness tools for municipal buyers.
Notable IP, approvals and regulatory items
Sunshine Biopharma (SBFM) received Health Canada approval for atenolol, supporting government‑channel revenue in cardiovascular therapeutics.
Other operational and compliance notes
Profusa (PFSA) announced compliance with Nasdaq publicly held shares listing requirements, clearing a governance overhang and restoring standard market access.
MicroVision (MVIS) regained compliance with Nasdaq's continued listing rules, removing a regulatory cloud for near‑term investors.
Updated: Mobix and production ramp
Mobix Labs (MOBX) updated its acquisition target: Vision Aerial has begun production of the American‑built Vulcan drone family, opened order intake and projects 93% revenue growth in 2027. That ramp reduces integration timing risk and gives clearer top‑line leverage ahead of the pending deal.
Don't miss out on market-moving news. Bookmark this page and check back regularly for the most recent updates on stocks, sectors, and the overall market landscape. Stay informed, stay ahead, and make smarter investment choices with our comprehensive stock news coverage.
Stay ahead of the market with our list of today's most important stock news and financial updates. Whether you're a day trader, long-term investor, or market enthusiast, our news feed covers everything you need to know about publicly traded companies.
Our news feed is designed for investors who want to stay informed about the latest developments affecting their portfolio or watchlist. Whether you're researching potential investments, monitoring your current holdings, or simply staying up-to-date with market trends, our stock news page provides the information you need to make informed decisions.
What You'll Find on This Page:
- Breaking financial news and market-moving headlines
- FDA approvals and clinical trial results for biotech and pharma stocks
- Stock offerings, dividends, and other corporate actions
- Mergers, acquisitions, and strategic partnerships
- Business news affecting company performance and stock prices
- Easy-to-use tags for quick news categorization
- Stock tickers for instant company identification
- AI sentiment analysis to gauge market reaction
- Estimated impact scores to assess potential stock movement